ISG-GEIS-FSG
GEIS-37
Phase I-II prospective trial, multicenter, open label, exploring the combination of trabectedin plus radiotherapy in soft tissue sarcoma patients (TRASTS)
Review Platform
User:
Password:
Forgot your password?
Contact
Site optimized for:
Firefox / IE6 or superior.